Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection

BACKGROUND: Post‐marketing pharmacovigilance data are scant on the safety of Covid‐19 vaccines among people with previous SARS‐CoV‐2 infection compared with ordinary vaccine recipients. We compared the post‐vaccination adverse events of special interests (AESI), accident and emergency room (A&E)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Francisco Tsz Tsun, Huang, Lei, Peng, Kuan, Li, Xue, Chui, Celine Sze Ling, Wan, Eric Yuk Fai, Wong, Carlos King Ho, Chan, Esther Wai Yin, Hung, Ivan Fan Ngai, Wong, Ian Chi Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303328/
https://www.ncbi.nlm.nih.gov/pubmed/35043503
http://dx.doi.org/10.1111/joim.13453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303328/
https://www.ncbi.nlm.nih.gov/pubmed/35043503
http://dx.doi.org/10.1111/joim.13453

Ejemplares similares